Oral Kontraseptiflerle İlgili Adli Tıp Sorunları

Öz

Oral kontraseptifleri oneren bir hekim onlann ne §ekilde etki ettikleri, diger etkilerinir neler oldugu, hangi tehlikeleri ta§IdIklan ve bu tehlikelerin slklIgml ve §iddetini azaltma~ i9in hangi onlemlerin aimmasl gerekecegini bilmek yiikiimliiliigiindedir. Bir hekime oral kontraseptif kullammi konusunda a§agidaki nedenlerle sorumluluk yiik lenebilir: Hastamn anamnezini tam olarak almamak, hastaYI aynntJlI bir §ekilde muayent etmemek, hastaYI ilgiJj riskier konusunda yeterince uyarmamak, hastamn aydmlatIlml§ nzaSIm almamak, hastaYI ters reaksiyonlarla ilgili semptomlar yoniinden izlememek, trom boflebitli bir hastaYI te§his etmemek, oral kontraseptifierin kullamml ile gebe kalma zamam arasmda bir bekleme donemi onermemek. Bu yazida yazarlar oral kontraseptifierin kullammmm adJi-tlbbi yonJerini ele almI§lardlr. Bu yazi hekimlere oral kontraseptifierin kullamml ile ilgili yasal yonlerin esaSlDl daha iyi kavramalanm ve gelecekteki bu tiir olgularda biigiierini daha yarari1 bir §ekilde uyguJa malanm sagiayacaktlr.

Anahtar Kelimeler

• Adli tıp sorunları
• Oral kontraseptifler
• Olgu

Kaynakça

1. Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol 1999 Jun;180(6 Pt 2):S343-8.
2. Goldsmith L. Medical Malpractice, Guide to Medical Issues, Volume 5, Part VII, Matthew Bender, New York, 1986; pp. 89/1-89/28.
3. Fineberg K S, Peters J D, Willson J R, Kroll D A. Obstetrics / Gynecclogy and the Law, Health Administration Press, Michigan, 1984; pp.305-31I.
4. Tatum Hl. Contraception & Family Planning, In. Pernoll ML (Editor) : Current Obstetric & Treatment, Edition 7, Appleton & Lange, 1991; pp.670-674.
5. Miller C. The combined oral contraceptive. A practical guide. Aust Fam Physician 1990; lun; 19(6):897,900,903-6.
6. Wall DM, Roos MP. Update on combination oral contraceptives. Am Fam Physician, 1990; Oct;42(4):\037 48.
7. Elstein M. Clinical Aspects of Litigation in Contraceptive Practice, In:Chamberlain, G.V.P., Orr. C.J.B., Sharp F (Editors) :Litigation and Obstetrics and Gynaecology, The Royal College of Obstetricians and GynaecologistslRichard Bates Limited, London, 1985; pp. 135-145.
8. Anderson M. Medico-Legal Problems in Gynaecology, In: Lewis, T.L.T., Chamberlain, G.V.P (Editors): Gynaecology by Ten Teachers, Edward Arnold, London, Melbourne, Auckland, 1990; p.282.

9. Rosenberg L. Palmer JR, Sands ML, Grimes D, Bergman U, Daling J, Mills A: Modem oral contraceptives and cardiovascular disease. Am J Obstet Gynecol1997; Sep;I77(3):707-15.
10. Mandell M S. Medicolegal Problems and Responsibilities, In:Nichols, D.H .. Evrard, J.R (Editors):Ambulatory Gynecology, Harper and Row. Publishers, 1985; pp.508-509.
11. Thorogood M. Oral contraceptives and myocardial infarction :new evidence leaves unanswered questions. Thromb Haemost. 1997; Jul;78(1):334-8.
12. Lewis S M. Ob/Gyn Malpractice. Wiley Law Publications. John Wiley and Sons, Inc., New York, Chichester, Brisbane, Toronto, Singapore, 1986; pp.424-431.
13. Castelli WP. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contracep tives who smoke. Am J Obstet Gynecol, 1999; Jun;180(6 Pt 2):S349-56.
14. Pitsavos C, Stefanadis C, Toutouzas P. Contraception in women at high risk or with established cardiovas cular disease. Ann N Y Acad Sci 2000; 900:215-27.
15. Sondheimer SJ. Update on oral contaceptive pills and postcoital contraception. Curr Opin Obstet Gynecol, 1992; Aug;4(4):502-5.
16. Vessey M P, Lawless M. McPherson, K and Yeates, D: Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet ii, 1983;930-934.
17. Fraser IS. Contraceptive choice for women with erisk factors!. Drug Saf, 1993; Apr;8(4):271-9.
18. Beck W W. Obstetrics and Gynecology, 2 nd Edition, Harwal Publishing Company, Pennsylvania, 1990; p.386.
19. Samsioe G, Mattsson LA. Some aspects of the relationship between oral contaceptives, lipid abnormalities, and cardiovascular disease. Am J Obstet Gynecol, 1990; Jul;163(l Pt 2):354-8.
20. Poindexter AN. Third-generation oral contraceptives and thromboembolism risk. Obstet Gynecol, 1997; Jun;89(6): 1028-30.
21. Rozovsky F A.Consent to Treatment, A Practical Guide, Second Edition, Little, Brown and Company, Boston, Toronto, London, 1990; pp. 279-285.
22. Easley H A. Medico-Legal Issues in Gynecology, In:Clarke-Pearson,D.L., Dawood, M.Y (Editors):Greenfs Gynecology, Fourth Edition, Little, Brown and Company, Boston, Toronto, London, 1990.
23. Newton M. Bouer R. Legal and Ethical Complications, In: Newton, M., Newton, E.R (Editors): Complications of Gynecologic and Obstetric Management, W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, 1988; p. 507.
24. Wall J A. Litigation Arising in the Field of Contraception, In: Chamberlain, G.V.P., Orr, C.J.B., Sharp, F (Editors): Litigation and Obstetrics and Gynaecology, The Royal College of Obstetricians and Gynaecologists I Richard Bates Limited, London, 1985; pp. 147-151.
25. Shipway R R H. Medicolegal Aspects, In: Gradzinskas, G., Beedham, T (Editors) : Treatment and Prognosis, Obstetrics and Gynaecology, Heinemann Professional Publishing, London, 1988.
26. Orr C. Contraception, In: Chamberlain, G., Orr, C (Editors) : How to Avoid Medico-Legal Problems in Obstetrics and Gynaecology, The Royal College of Obstetricians and Gynaecologistsl The Chameleon Press Limited, 1990; pp. 69-73.
27. Hansen TH, Lundvall F. Factors influencing the reliability of oral contraceptives. Acta Obstet Gynecol Scand. 1997; Jan; 76(1):61-4.
28. Kovacs GT, Riddoch G, Duncombe P, Welberry L, Chick P, Weisberg E, Leavesley GM, Baker HW. Inadvertent pregnancies in oral contraceptive users. Med J Aust, 1989; May 15;150(10):549-51.